Valuation: IDEXX Laboratories, Inc.

Market Cap 46.93B 40.66B 38.02B 34.75B 65.42B 4,472B 66.52B 445B 175B 2,238B 176B 172B 7,474B P/E 2026 *
40.4x
P/E 2027 * 35.7x
Enterprise Value 47.27B 40.95B 38.29B 35B 65.89B 4,505B 67.01B 448B 176B 2,254B 177B 174B 7,528B EV / Sales 2026 *
10x
EV / Sales 2027 * 9.11x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+0.43%
1 week+8.03%
Current month+8.03%
1 month+6.94%
1 week 469.58
Extreme 469.5795
483.21
1 month 441.57
Extreme 441.5665
483.21
Current year 423.56
Extreme 423.5615
483.21
1 year 423.56
Extreme 423.5615
483.21
3 years 423.56
Extreme 423.5615
483.21
5 years 423.56
Extreme 423.5615
483.21
10 years 423.56
Extreme 423.5615
483.21
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+8.03% - - 46.22B
+1.55%+6.56%-9.47%+14.85% 46.22B
Average +0.99%+1.30%-9.47%+14.85% 46.22B
Weighted average by Cap. +0.99%+1.30%-9.47%+14.85%

Financials

2026 *2027 *
Net sales 4.72B 4.09B 3.83B 3.5B 6.58B 450B 6.7B 44.78B 17.58B 225B 17.73B 17.35B 752B 5.14B 4.45B 4.16B 3.81B 7.16B 490B 7.29B 48.73B 19.13B 245B 19.29B 18.88B 819B
Net income 1.18B 1.02B 954M 872M 1.64B 112B 1.67B 11.16B 4.38B 56.14B 4.42B 4.32B 187B 1.31B 1.14B 1.06B 973M 1.83B 125B 1.86B 12.46B 4.89B 62.65B 4.93B 4.83B 209B
Net Debt 340M 294M 275M 251M 473M 32.37B 481M 3.22B 1.26B 16.2B 1.27B 1.25B 54.09B -124M -107M -100M -91.56M -172M -11.78B -175M -1.17B -460M -5.9B -464M -454M -19.69B
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change
10/08/26 CHF 483.21 +0.43%
07/08/26 CHF 481.15 +1.58%
06/08/26 CHF 473.64 +0.87%
05/08/26 CHF 469.58 -1.97%
04/08/26 CHF 479.03 +4.12%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
586.67USD
Average target price
705.85USD
Spread / Average Target
+20.31%

Quarterly revenue - Rate of surprise